We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GRAL market cap is 698.22M. The company's latest EPS is USD -43.6206 and P/E is -0.48.
Quarter End | |
---|---|
USD (US$) | |
Total Revenue | |
Operating Income | |
Net Income |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Revenue | 93.11M |
Operating Income | -1.52B |
Net Income | -1.47B |
Quarter End | |
---|---|
USD (US$) | |
Total Assets | |
Total Liabilities | |
Total Equity |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Assets | 3.91B |
Total Liabilities | 267.63M |
Total Equity | 3.65B |
Market Cap | 698.22M |
Price to Earnings Ratio | -0.48 |
Price to Sales Ratio | 7.5 |
Price to Cash Ratio | 7.18 |
Price to Book Ratio | 0.19 |
Dividend Yield | - |
Shares Outstanding | 33.6M |
Average Volume (1 week) | 864.87k |
Average Volume (1 Month) | 877.01k |
52 Week Change | 11.54% |
52 Week High | 23.44 |
52 Week Low | 12.33 |
Spread (Intraday) | 1.5 (6.73%) |
Company Name | GRAIL Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://grail.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions